Global Spinal Muscular Atrophy (SMA) Therapeutic Market Growth (Status and Outlook) 2022-2028
- LP 4890882
- 85 Pages
- March 2022
- Medical Devices
The United States Spinal Muscular Atrophy (SMA) Therapeutic market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Spinal Muscular Atrophy (SMA) Therapeutic market, reaching US$ million by the year 2028. As for the Europe Spinal Muscular Atrophy (SMA) Therapeutic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Spinal Muscular Atrophy (SMA) Therapeutic players cover Biogen, Novartis, Roche, and Astellas Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Spinal Muscular Atrophy (SMA) Therapeutic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Nusinersen
Onasemnogen Abeparvovec
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Type 1 SMA
Type 2 SMA
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Biogen
Novartis
Roche
Astellas Pharma
Genzyme Corporation
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2017-2028
2.1.2 Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Spinal Muscular Atrophy (SMA) Therapeutic Segment by Type
2.2.1 Nusinersen
2.2.2 Onasemnogen Abeparvovec
2.3 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
2.3.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2017-2022)
2.4 Spinal Muscular Atrophy (SMA) Therapeutic Segment by Application
2.4.1 Type 1 SMA
2.4.2 Type 2 SMA
2.4.3 Other
2.5 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
2.5.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2017-2022)
3 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Player
3.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Players
3.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue by Players (2020-2022)
3.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Players (2020-2022)
3.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Spinal Muscular Atrophy (SMA) Therapeutic by Regions
4.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions (2017-2022)
4.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2017-2022)
4.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2017-2022)
4.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2017-2022)
4.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth (2017-2022)
5 Americas
5.1 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2017-2022)
5.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2017-2022)
5.3 Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2017-2022)
6.2 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2017-2022)
6.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic by Country (2017-2022)
7.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2017-2022)
7.3 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic by Region (2017-2022)
8.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2017-2022)
8.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Regions (2023-2028)
10.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Regions (2023-2028)
10.1.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.1.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.1.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.1.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Forecast
10.2 Americas Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Country (2023-2028)
10.2.1 United States Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.2.2 Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.2.3 Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.2.4 Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3 APAC Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Region (2023-2028)
10.3.1 China Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.2 Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.3 Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.4 Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.5 India Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.3.6 Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Country (2023-2028)
10.4.1 Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.2 France Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.3 UK Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.4 Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.4.5 Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Region (2023-2028)
10.5.1 Egypt Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.2 South Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.3 Israel Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.4 Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.5.5 GCC Countries Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast
10.6 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Type (2023-2028)
10.7 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.1.3 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.2.3 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.3.3 Roche Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Information
11.4.2 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.4.3 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Astellas Pharma Main Business Overview
11.4.5 Astellas Pharma Latest Developments
11.5 Genzyme Corporation
11.5.1 Genzyme Corporation Company Information
11.5.2 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
11.5.3 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Genzyme Corporation Main Business Overview
11.5.5 Genzyme Corporation Latest Developments
12 Research Findings and Conclusion
Table 1. Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Nusinersen
Table 3. Major Players of Onasemnogen Abeparvovec
Table 4. Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2017-2022)
Table 7. Spinal Muscular Atrophy (SMA) Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2017-2022)
Table 10. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Player (2020-2022)
Table 12. Spinal Muscular Atrophy (SMA) Therapeutic Key Players Head office and Products Offered
Table 13. Spinal Muscular Atrophy (SMA) Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Regions (2017-2022)
Table 18. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Country (2017-2022)
Table 20. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2017-2022)
Table 22. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2017-2022)
Table 24. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region (2017-2022)
Table 26. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2017-2022)
Table 28. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2017-2022)
Table 30. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Country (2017-2022)
Table 32. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2017-2022)
Table 34. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Spinal Muscular Atrophy (SMA) Therapeutic
Table 43. Key Market Challenges & Risks of Spinal Muscular Atrophy (SMA) Therapeutic
Table 44. Key Industry Trends of Spinal Muscular Atrophy (SMA) Therapeutic
Table 45. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share Forecast by Application (2023-2028)
Table 51. Biogen Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 52. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 53. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 57. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis Latest Developments
Table 61. Roche Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 62. Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 63. Roche Main Business
Table 64. Roche Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Roche Latest Developments
Table 66. Astellas Pharma Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 67. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 68. Astellas Pharma Main Business
Table 69. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Astellas Pharma Latest Developments
Table 71. Genzyme Corporation Details, Company Type, Spinal Muscular Atrophy (SMA) Therapeutic Area Served and Its Competitors
Table 72. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Offered
Table 73. Genzyme Corporation Main Business
Table 74. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Genzyme Corporation Latest Developments
List of Figures
Figure 1. Spinal Muscular Atrophy (SMA) Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type in 2021
Figure 7. Spinal Muscular Atrophy (SMA) Therapeutic in Type 1 SMA
Figure 8. Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Type 1 SMA (2017-2022) & ($ Millions)
Figure 9. Spinal Muscular Atrophy (SMA) Therapeutic in Type 2 SMA
Figure 10. Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Type 2 SMA (2017-2022) & ($ Millions)
Figure 11. Spinal Muscular Atrophy (SMA) Therapeutic in Other
Figure 12. Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application in 2021
Figure 14. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Player in 2021
Figure 15. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2017-2022 ($ Millions)
Figure 17. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2017-2022 ($ Millions)
Figure 18. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2017-2022 ($ Millions)
Figure 20. Americas Spinal Muscular Atrophy (SMA) Therapeutic Value Market Share by Country in 2021
Figure 21. Americas Spinal Muscular Atrophy (SMA) Therapeutic Consumption Market Share by Type in 2021
Figure 22. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application in 2021
Figure 23. United States Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region in 2021
Figure 28. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application in 2021
Figure 29. China Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Country in 2021
Figure 36. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type in 2021
Figure 37. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application in 2021
Figure 38. Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Application in 2021
Figure 46. Egypt Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 52. APAC Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 53. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 55. United States Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 56. Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 59. China Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 60. Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 61. Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 63. India Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 64. Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 65. Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 66. France Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 67. UK Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 68. Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 69. Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 70. Spain Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 73. Israel Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Spinal Muscular Atrophy (SMA) Therapeutic Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
